Anika Therapeutics, Inc.ANIKNASDAQ
LOADING
|||
Price to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Price-to-sales ratio
Latest
2.02
↓ 58% below average
Average (9y)
4.80
Historical baseline
Range
High:6.95
Low:2.02
CAGR
-11.6%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 2.02 | -26.5% |
| 2023 | 2.75 | -27.4% |
| 2022 | 3.79 | +8.5% |
| 2021 | 3.49 | -29.2% |
| 2020 | 4.93 | -22.8% |
| 2019 | 6.39 | +38.9% |
| 2018 | 4.60 | -33.6% |
| 2017 | 6.93 | -0.4% |
| 2016 | 6.95 | +13.5% |
| 2015 | 6.13 | - |